RACHEL PERKINS: Open Payments
NPI 1750924676 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,331 in 142 payments from 15 companies in 2025. Trend: 2023 $1,518 · 2024 $1,990 · 2025 $2,331
Food & beverage: $2,269Education: $61
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $326 |
| ABBVIE INC. | 25 | $322 |
| UCB, Inc. | 18 | $310 |
| Regeneron Healthcare Solutions, Inc. | 8 | $303 |
| Galderma Laboratories, L.P. | 26 | $244 |
| GENZYME CORPORATION | 16 | $228 |
| Novartis Pharmaceuticals Corporation | 10 | $161 |
| Amgen Inc. | 9 | $139 |
| LEO Pharma Inc. | 5 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
Products named: DUPIXENT, TREMFYA, Bimzelx, NEMLUVIO, RINVOQ, OTEZLA, SKYRIZI, COSENTYX.
Industry payments across KY — which companies pay providers there.
